Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy
CompletedOBSERVATIONAL
Enrollment
173
Participants
Timeline
Start Date
June 15, 2020
Primary Completion Date
March 15, 2023
Study Completion Date
March 15, 2023
Conditions
Severe Aplastic Anemia
Trial Locations (1)
20892
National Heart, Lung and Blood Institute (NHLBI), Bethesda
All Listed Sponsors
lead
National Heart, Lung, and Blood Institute (NHLBI)
NIH
NCT04436380 - Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy | Biotech Hunter | Biotech Hunter